KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Enterprise Value (2021 - 2026)

Staar Surgical's Enterprise Value history spans 17 years, with the latest figure at -$187.5 million for Q1 2026.

  • For Q1 2026, Enterprise Value rose 18.64% year-over-year to -$187.5 million; the TTM value through Jan 2026 reached -$187.5 million, up 18.64%, while the annual FY2026 figure was -$187.5 million, 18.64% up from the prior year.
  • Enterprise Value reached -$187.5 million in Q1 2026 per STAA's latest filing, up from -$192.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$187.5 million in Q1 2026 to a low of -$245.1 million in Q1 2024.
  • Average Enterprise Value over 5 years is -$210.2 million, with a median of -$207.6 million recorded in 2022.
  • Peak YoY movement for Enterprise Value: fell 25.43% in 2024, then rose 19.27% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$211.6 million in 2022, then decreased by 4.29% to -$220.7 million in 2023, then decreased by 4.43% to -$230.5 million in 2024, then grew by 16.41% to -$192.7 million in 2025, then increased by 2.66% to -$187.5 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Enterprise Value are -$187.5 million (Q1 2026), -$192.7 million (Q3 2025), and -$189.9 million (Q2 2025).